Weaning Of Immunosuppression In Long‐Term Liver Transplant Recipients

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Transplantation

• Publication date

  1995-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00007890-199501000-00010PMID 7839442PMCID PMC3005337
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Structural integrity and identification of causes of liver allograft dysfunction occurring more than 5 years after transplantation.

  1995cited by this paper
• Transplantation milestones. Viewed with one- and two-way paradigms of tolerance.

  1995cited by this paper
• Weaning of immunosuppression in long-term recipients of living related renal transplants: a preliminary study.

  1995cited by this paper
• Murine liver allograft transplantation: Tolerance and donor cell chimerism

  1994cited by this paper
• Cyclosporine withdrawal for nephrotoxicity in liver transplant recipients does not result in sustained improvement in kidney function and causes cellular and ductopenic rejection

  1994cited by this paper
• SPLIT TOLERANCE INDUCED BY ORTHOTOPIC LIVER TRANSPLANTATION IN MICE1

  1994cited by this paper
• Spontaneous and iatrogenically augmented leukocyte chimerism in organ transplant recipients.

  1994cited by this paper
• Frequent achievement of a drug-free state after orthotopic liver transplantation.

  1993cited by this paper
• Donor cell chimerism permitted by immunosuppressive drugs: a new view of organ transplantation.

  1993cited by this paper
• Cell migration and chimerism after whole‐organ transplantation: The basis of graft acceptance

  1993cited by this paper
• Cell migration, chimerism, and graft acceptance.

  1992cited by this paper
• Hepatotrophic effects of FK506 in dogs.

  1991cited by this paper
• The hepatotropic influence of cyclosporine.

  1990cited by this paper
• A new in vitro approach to determine acquired tolerance in long-term kidney allograft recipients.

  1990cited by this paper
• FK 506 for liver, kidney, and pancreas transplantation.

  1989cited by this paper
• Failure of in vitro assays to predict accurately the existence of neonatally induced H-2 tolerance.

  1989cited by this paper
• CELL‐MEDIATED LYMPHOLYSIS STUDIES IN RENAL ALLOGRAFT RECIPIENTS

  1981cited by this paper
• Immunological monitoring of long-surviving renal transplant recipients.

  1977cited by this paper

• Immunosuppression minimization and withdrawal in liver transplantation: The "holy grail"?

  2025cites this paper
• Immunomodulation in post-transplant diabetes mellitus: Challenges and management.

  2025cites this paper
• B Cell–mediated Immune Regulation and the Quest for Transplantation Tolerance

  2024cites this paper
• Colorectal cancer in ulcerative colitis after liver transplantation for primary sclerosing cholangitis: a systematic review and pooled analysis of oncological outcomes

  2024cites this paper
• Leveraging the lymphohematopoietic graft-versus-host reaction (LGVHR) to achieve allograft tolerance and restore self tolerance with minimal toxicity

  2023cites this paper
• Chimeric Antigen Receptor (CAR) Regulatory T-Cells in Solid Organ Transplantation

  2022cites this paper
• TCL1A, B Cell Regulation and Tolerance in Renal Transplantation

  2021cites this paper
• Advances in Liver Transplantation: where are we in the pursuit of transplantation tolerance?

  2021cites this paper
• Clinical parameters and biomarkers predicting spontaneous operational tolerance after liver transplantation: A scoping review

  2021cites this paper
• Live Vaccines in Pediatric Liver Transplant Recipients: “To Give or Not to Give”

  2021cites this paper
• Clinical liver transplant tolerance: Recent topics

  2021cites this paper
• Dermatological signs in liver transplant recipients

  2021cites this paper
• Clinical parameters and biomarkers predicting spontaneous operational tolerance after liver transplantation: a scoping review protocol.

  2020cites this paper
• Tolerance studies in liver transplantation: are we fooling ourselves?

  2020cites this paper
• Clinical parameters and biomarkers predicting spontaneous operational tolerance after liver transplantation: a scoping review protocol

  2020cites this paper
• Strategies for Deliberate Induction of Immune Tolerance in Liver Transplantation: From Preclinical Models to Clinical Application

  2020cites this paper
• The Next Frontier of Regulatory T Cells: Promising Immunotherapy for Autoimmune Diseases and Organ Transplantations

  2020cites this paper
• Steroid‐sparing maintenance immunosuppression is safe and effective after simultaneous liver‐kidney transplantation

  2020cites this paper
• Clinical parameters and biomarkers predicting spontaneous operational tolerance after liver transplantation: a scoping review protocol.

  2019cites this paper
• Dermatological Disorders following Liver Transplantation: An Update

  2019cites this paper
• Why some organ allografts are tolerated better than others: new insights for an old question

  2019cites this paper
• Revisiting the liver’s role in transplant alloimmunity

  2019cites this paper
• De novo malignancies after liver transplantation: The effect of immunosuppression-personal data and review of literature

  2019cites this paper
• Serial Monitoring of Immune Markers Being Represented Regulatory T Cell/T Helper 17 Cell Ratio: Indicating Tolerance for Tapering Immunosuppression after Liver Transplantation

  2018cites this paper
• Durable Clinical and Immunologic Advantage of Living Donor Liver Transplantation in Children

  2018cites this paper
• Effects of the calcineurin inhibitors cyclosporine and tacrolimus on bone metabolism in rats.

  2018cites this paper
• New frontiers in immunosuppression.

  2018cites this paper
• Regulatory T‐cell therapy in liver transplantation

  2017cites this paper
• Tolerance after liver transplantation: Where are we?

  2017cites this paper
• STUDY OF DRUG RELATED PROBLEMS IN ORGAN TRANSPLANT PATIENTS

  2017cites this paper
• Hepatic Stellate Cells Directly Inhibit B Cells via Programmed Death–Ligand 1

  2016cites this paper
• This information is current as Ligand 1 − via Programmed Death Hepatic Stellate Cells Directly Inhibit B Cells

  2016cites this paper
• LIVER TRANSPLANTATION: FROM A HISTOPATHOLOGIST’S PERSPECTIVE

  2016cites this paper
• Management of immunosuppressant agents following liver transplantation: Less is more.

  2016cites this paper
• Spontaneous and induced tolerance for liver transplant recipients

  2016cites this paper
• Organ-specific differences in achieving tolerance

  2015cites this paper
• Immune Reconstitution/Immunocompetence in Recipients of Kidney Plus Hematopoietic Stem/Facilitating Cell Transplants

  2015cites this paper
• Suicidal emperipolesis: a process leading to cell-in-cell structures, T cell clearance and immune homeostasis.

  2015cites this paper
• Chapter 102 – Genetic and Genomic Potential in Liver Transplantation

  2015cites this paper
• Minimization or withdrawal of immunosuppressants in pediatric liver transplant recipients.

  2015cites this paper
• [Skin manifestations in adults with a liver allograft].

  2015cites this paper
• Incidence and impact of rejection following simultaneous liver-kidney transplantation.

  2015cites this paper
• Reconsidering the detection of tolerance to individualize immunosuppression minimization and to improve long‐term kidney graft outcomes

  2015cites this paper
• Immunosuppression withdrawal following liver transplantation.

  2014cites this paper
• End Stage Liver Disease Clinical Immune Tolerance in Liver Transplantation : Present and Future

  2014cites this paper
• Pediatric transplantation and tolerance: Past, present, and future

  2014cites this paper
• Expression of alpha smooth muscle actin in living donor liver transplant recipients.

  2014cites this paper
• Characteristics of recipients who achieved spontaneous operational tolerance in adult liver transplantation.

  2013cites this paper
• Liver Transplant Tolerance and Its Application to the Clinic: Can We Exploit the High Dose Effect?

  2013cites this paper
• Markers of operational immune tolerance after pediatric liver transplantation in patients under immunosuppression

  2013cites this paper
• Tissue biopsy monitoring of operational tolerance in liver allograft recipients

  2013cites this paper
• Tolerance Induction in HLA Disparate Living Donor Kidney Transplantation by Donor Stem Cell Infusion: Durable Chimerism Predicts Outcome

  2013cites this paper
• Transplantation tolerance

  2013cites this paper
• Human Hepatic Stellate Cells Inhibit T-Cell Response Through B7-H1 Pathway

  2013cites this paper
• Calcineurin inhibitor minimisation versus continuation of calcineurin inhibitor treatment for liver transplant recipients.

  2012cites this paper
• Tolerance in liver transplantation.

  2012cites this paper
• Importance of liver biopsy findings in immunosuppression management: biopsy monitoring and working criteria for patients with operational tolerance.

  2012cites this paper
• The adolescent and liver transplantation.

  2012cites this paper
• Plasmacytoid Dendritic Cells Are Key Regulators of Immune Tolerance

  2012cites this paper
• Complete immunosuppression withdrawal and subsequent allograft function among pediatric recipients of parental living donor liver transplants.

  2012cites this paper
• BIOMARKERS OF OPERATIONAL TOLERANCE IN SOLID ORGAN TRANSPLANTATION.

  2012cites this paper
• Chapter 96 – Liver and pancreas transplantation immunobiology

  2012cites this paper
• Importance of liver biopsy findings in immunosuppression management: Biopsy monitoring and working criteria for patients with operational tolerance

  2012influential citation
• Hepatitis C virus recurrence and immunosuppression-free state after liver transplantation

  2012influential citation
• Causes of mortality after liver transplantation: a single center experience in mainland china.

  2012cites this paper
• Role of the Hepatic Parenchyma in Liver Transplant Tolerance: A Paradigm Revisited

  2011cites this paper
• Approaching the Promise of Operational Tolerance in Clinical Transplantation

  2011cites this paper
• Favoring the risk-benefit balance for upper extremity transplantation--the Pittsburgh Protocol.

  2011cites this paper
• HLA-G Level on Monocytoid Dendritic Cells Correlates With Regulatory T-Cell Foxp3 Expression in Liver Transplant Tolerance

  2011cites this paper
• Tolerancia inmunológica en el trasplante hepático

  2011cites this paper
• Finding the right time for weaning off immunosuppression in solid organ transplant recipients

  2010cites this paper
• Identification of a B cell signature associated with renal transplant tolerance in humans.

  2010cites this paper
• WEANING OF IMMUNOSUPPRESSION IN LIVER TRANSPLANT RECIPIENTS 1,2

  2010cites this paper
• CD40-CD40L costimulation blockade induced the tolerogenic dendritic cells in mouse cardiac transplant.

  2010cites this paper
• Intratumoral Neoadjuvant Immunotherapy Using IL-12 and Dendritic Cells Is an Effective Strategy To Control Recurrence of Murine Hepatocellular Carcinoma in Immunosuppressed Mice

  2010cites this paper
• Heterogeneous Inflammatory Changes in Liver Graft Recipients With Normal Biochemistry

  2010cites this paper
• Role of T cells in graft rejection and transplantation tolerance

  2010cites this paper
• Tolerance: is it achievable in pediatric solid organ transplantation?

  2010cites this paper
• Report of the first international liver transplantation society expert panel consensus conference on renal insufficiency in liver transplantation

  2009cites this paper
• Operational tolerance after liver transplantation.

  2009cites this paper
• Monitoring of human liver and kidney allograft tolerance: a tissue/histopathology perspective

  2009influential citation
• Unique aspects of rejection and tolerance in liver transplantation.

  2009cites this paper
• PREVALENCE , IMPACT , AND ETIOLOGY OF RENAL INSUFFICIENCY IN LIVER TRANSPLANTATION Scope of the Problem and Impact on Outcomes

  2009cites this paper
• Requirement of Protocol Biopsy Before and After Complete Cessation of Immunosuppression After Liver Transplantation

  2009cites this paper
• Monitoring Regulatory T-Cells after Transplantation: Is It Useful?

  2009cites this paper
• Special article Operational tolerance after liver transplantation q

  2009cites this paper
• Long-term Management of Immunosuppression After Pediatric Liver Transplantation : Is Minimization or Withdrawal Desirable and / or Possible ?

  2009cites this paper
• Distinct response of liver myeloid dendritic cells to endotoxin is mediated by IL-27.

  2009cites this paper
• Exhaustive Differentiation of Alloreactive CD8+ T Cells: Critical for Determination of Graft Acceptance or Rejection

  2008cites this paper
• Long-term management of immunosuppression after pediatric liver transplantation: is minimization or withdrawal desirable or possible or both?

  2008cites this paper
• Infectious complications in extended criteria heart transplantation.

  2008cites this paper
• Long-term outcomes after liver transplantation in children

  2008cites this paper
• Protocol Liver Allograft Biopsies

  2008cites this paper
• Screening liver transplant patients for tolerance

  2008cites this paper
• Improving Long‐Term Outcomes After Liver Transplantation in Children

  2008cites this paper
• Non-melanoma skin cancer: importance of gender, immunosuppressive status and vitamin D.

  2008cites this paper
• The Tor Vergata weaning off immunosuppression protocol in stable HCV liver transplant patients: the updated follow up at 78 months.

  2008cites this paper
• Clinical tolerance following liver transplantation: long term results and future prospects.

  2007cites this paper
• Activation and effector function of unconventional acute rejection pathways studied in a hepatocellular allograft model

  2007cites this paper
• A randomised controlled trial of total immunosuppression withdrawal in stable liver transplant recipients

  2007cites this paper